Human urocortin II: mild locomotor suppressive and delayed anxiolytic-like effects of a novel corticotropin-releasing factor related peptide
about
sameAs
Effect of lamotrigine and carbamazepine on corticotropin-releasing factor-associated serotonergic transmission in rat dorsal raphe nucleusNeuroanatomical evidence for reciprocal regulation of the corticotrophin-releasing factor and oxytocin systems in the hypothalamus and the bed nucleus of the stria terminalis of the rat: Implications for balancing stress and affectHypoactivation of CRF receptors, predominantly type 2, in the medial-posterior BNST is vital for adequate maternal behavior in lactating rats.Anxiolytic-like effects of antisauvagine-30 in mice are not mediated by CRF2 receptors.Behavioral Studies and Genetic Alterations in Corticotropin-Releasing Hormone (CRH) Neurocircuitry: Insights into Human Psychiatric Disorders.A triple urocortin knockout mouse model reveals an essential role for urocortins in stress recoveryEffects of acidic-astressin and ovine-CRF microinfusions into the ventral hippocampus on defensive behaviors in rats.Disruption of the CRF(2) receptor pathway decreases the somatic expression of opiate withdrawal.Corticotropin-releasing factor 1 antagonists selectively reduce ethanol self-administration in ethanol-dependent ratsA CRF(2) agonist administered into the central nucleus of the amygdala decreases ethanol self-administration in ethanol-dependent rats.Physiology, pharmacology, and therapeutic relevance of urocortins in mammals: ancient CRF paralogs.Corticotropin-releasing factor receptors in the dorsal raphe nucleus modulate social behavior in Syrian hamsters.Anxiogenic and aversive effects of corticotropin-releasing factor (CRF) in the bed nucleus of the stria terminalis in the rat: role of CRF receptor subtypes.Emergence of anxiety-like behaviours in depressive-like Cpe(fat/fat) miceOvarian steroid regulation of the midbrain corticotropin releasing factor and urocortin systems in macaquesUrocortin 2 increases c-Fos expression in serotonergic neurons projecting to the ventricular/periventricular system.Corticotropin releasing factor: a key role in the neurobiology of addictionDifferential monoaminergic, neuroendocrine and behavioural responses after central administration of corticotropin-releasing factor receptor type 1 and type 2 agonists.Effects of citalopram on serotonin and CRF systems in the midbrain of primates with differences in stress sensitivity.Neuropeptides: implications for alcoholism.The therapeutic potential of CRF1 antagonists for anxiety.κ opioid regulation of anxiety-like behavior during acute ethanol withdrawal.Enhanced anxiety in the male offspring of sires that self-administered cocaine.The effect of citalopram on midbrain CRF receptors 1 and 2 in a primate model of stress-induced amenorrhea.Urocortin II increases spontaneous parental behavior in prairie voles (Microtus ochrogaster)Cellular adaptations of dorsal raphe serotonin neurons associated with the development of active coping in response to social stress.Animal models of nicotine exposure: relevance to second-hand smoking, electronic cigarette use, and compulsive smoking.Postnatal expression of corticotropin releasing factor (CRF) in rat urinary bladderProtracted withdrawal from ethanol and enhanced responsiveness stress: regulation via the dynorphin/kappa opioid receptor system.The effect of short moderate stress on the midbrain corticotropin-releasing factor system in a macaque model of functional hypothalamic amenorrhea.The role of CRF family peptides in the regulation of food intake and anxiety-like behavior.The CRF family of neuropeptides and their receptors - mediators of the central stress response.Expression of urocortin 2 and its inhibitory effects on intracellular ca2+ via L-type voltage-gated calcium channels in rat pheochromocytoma (PC12) cells.Sex differences in prenatally programmed anxiety behaviour in rats: differential corticotropin-releasing hormone receptor mRNA expression in the amygdaloid complex.Divergent role for CRF1 and CRF2 receptors in the modulation of visceral pain.
P2860
Q28564629-71DC5490-6F6C-4D5E-B4AD-15186FA2D233Q28565572-2F527D69-3829-4ACF-BFC6-998CFA123DB1Q30434209-35344159-CCB9-46C1-80BE-CE1E5568657EQ30449644-7D70D5C4-061D-457C-977C-984704C021F6Q30462467-E92B01F5-4385-4B30-9C9E-91B6457361DFQ30475603-9CA74827-59FC-4C3C-B642-AC06B9A53ECCQ30481245-0D532E3F-473C-4E01-8CD5-1D271E20091BQ30486052-4B0B099F-5A49-457B-99F2-3D6A90DE1936Q30486793-D2736581-1902-4B46-B7E8-64D1692EBE4FQ30486940-87CAD608-A688-4609-8067-4AD622F5D355Q30487401-4E94C0BD-D77C-478B-B896-8A21E29746FBQ30488089-BAAA2916-29DB-466B-8A4E-24525711FFBCQ30499863-BBDFE46F-0E36-43BF-8E9F-9BFF5764796AQ30562163-F599CDB9-C987-4393-9714-1F43A92D6C0FQ33690311-6C47A1AD-F905-4169-A017-7C9AE1607618Q33912708-FA72CB60-2CE7-4066-93B5-5BA62A733FC7Q34421204-7BD0403A-A8A9-4E41-86F7-C4D2F6A1996EQ34426100-42BCE723-D2A4-4767-A14E-E8D3454FCC31Q35119585-DDE1DDAC-3E37-44D6-BFFB-C9C8C3412A0EQ35729094-01F7D7E8-3FBD-4428-9DF1-9175D64FB64CQ35814456-50BDCFD8-065B-480F-B9F7-DA9D8E0D7ED8Q35965664-26309722-AA7B-4E79-AAE8-72B8AC319064Q36225911-41FB14B0-4782-4482-BC81-5CF4E1A141D1Q36225978-3240823F-C00F-47C4-AFF4-14B2E87CE33AQ36517680-15000795-1B77-429C-B057-77EA2C91BF59Q36828404-2116F2E2-66BA-4CAA-A2F5-9180CDE7AF13Q36900018-570823E8-9CFC-40EC-8B50-71C269FA5468Q36942368-E3D48F5F-5768-4463-B530-C2396EF68483Q36980041-E6863A23-5750-4197-8797-F63E96D42324Q37653080-DE97D2C7-58D1-497C-9993-3ABF72D0AE94Q38472576-E559D6C0-7861-40C5-AADE-7CF93CD4F35AQ38750612-3FF914E6-9B53-4DAD-B791-01F5CBFFE0F9Q48505917-79E32FD2-7AF9-4236-825C-1497A589A2ECQ48943140-0FA53E59-497D-429C-B07F-D0258E759D19Q51454045-281C9140-EC0F-4492-9685-D0100E405605
P2860
Human urocortin II: mild locomotor suppressive and delayed anxiolytic-like effects of a novel corticotropin-releasing factor related peptide
description
2002 nî lūn-bûn
@nan
2002 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Human urocortin II: mild locom ...... leasing factor related peptide
@ast
Human urocortin II: mild locom ...... leasing factor related peptide
@en
Human urocortin II: mild locom ...... leasing factor related peptide
@nl
type
label
Human urocortin II: mild locom ...... leasing factor related peptide
@ast
Human urocortin II: mild locom ...... leasing factor related peptide
@en
Human urocortin II: mild locom ...... leasing factor related peptide
@nl
prefLabel
Human urocortin II: mild locom ...... leasing factor related peptide
@ast
Human urocortin II: mild locom ...... leasing factor related peptide
@en
Human urocortin II: mild locom ...... leasing factor related peptide
@nl
P2093
P1433
P1476
Human urocortin II: mild locom ...... leasing factor related peptide
@en
P2093
Eric P Zorrilla
George F Koob
Glenn R Valdez
Jean Rivier
Koki Inoue
P304
P356
10.1016/S0006-8993(02)02707-5
P407
P50
P577
2002-07-05T00:00:00Z